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Flow diverters (FDs) are being used with increasing frequency, especially to target large 
and complex aneurysms not amenable to treatment with conventional endovascular 
methods.8,10,11,26 The Pipeline embolization device (PED) is the first FD approved by 
the FDA following the results of the PUFS trial for the management of large or giant 
wide-necked intracranial aneurysms in the internal carotid artery from the petrous to 
the superior hypophyseal segments. Although initially indicated for a limited type of 
aneurysms, the use of the PED is being extended for the management of a variety of 
aneurysms in different settings.5-7,9 The main factors that are considered in deciding if an 
aneurysm is suitable for treatment with the PED include aneurysm size, location, geom-
etry and shape and rupture status.16 Studies have shown a high technical success rate, 
a high rate of aneurysm occlusion accompanied by low recurrence and re-treatment 
rates.10,12,20 Current evidence also supports the PED as a safe device associated with 
low morbidity and mortality.10,21,23,27 Although treatment failure with flow diversion has 
been reported, the characteristics of these aneurysms with persistent filling have not 
been well established. Furthermore, the course of these aneurysms remains a topic of 
uncertainty. The initial thrombosis caused by FDs does not result in immediate cure of 
the aneurysm rather FDs act as a scaffold for endothelial overgrowth at the aneurysm 
neck resulting intra-aneurysmal flow stasis and thrombosis while promoting remodeling 
of the parent vessel and parent vessel reconstruction which results in gradual occlusion 
of the aneurysm.22  
Prior literature on the efficacy of PED have shown a high complete aneurysm occlu-
sion rate, with most studies reporting occlusion rates > 80% 3,13 and this compares 
favorably to endovascular coil embolization, where the reported complete occlusion 
rate is 66%( ISAT).4 Recurrence after successful PED treatment has not been reported 
with the available short- and medium-term data. This is in contrast to high recurrence 
rates with coiling (9-34% at 12 months) that increases with large, giant, wide-necked, 
and nonsaccular aneurysms that are the target for PED treatment.1 The retreatment 
rate is much lower with PED treatment as compared to coiling in ISAT (17.4%).4 Flow 
diverters seem to be more effective than the conventional endovascular techniques 
in select cases.
Aneurysm location in the distal anterior circulation (PCOM artery, anterior choroidal 
artery and MCA) is a significant predictor of persistent aneurysm. Parent vessels 
for such aneurysms are usually small, and aneurysms often arise at major branch 
points. In addition, the A1 segment of the ACA and M1 segment of the MCA are rich in 
lenticulo-striate perforators, and covering these areas with PEDs could theoretically 
increase the risk of perforator strokes with neurological deficits. These factors render 
PED delivery and deployment more difficult. Also, PEDs (with available sizes from 2.5 
to 5 mm) are in general designed for parent vessels that are larger than the caliber 
of distal anterior circulation vessels. In a small vessel, the device may be elongated 
and the stent pores may become larger which may impair the flow diversion effect 
and lower the chances of aneurysm 
thrombosis. This may affect the reliability 
of PED deployment in smaller distal 
vessels. However, there are some distal 
anterior circulation aneurysms that are 
morphologically challenging for either 
traditional microsurgical or endovas-
cular approaches, and the use of PEDs 
may have an advantage in these cases. 
In these cases, placing a single, long flow 
diverter stent and avoiding telescoping 
of multiple devices along perforator-rich 
segments can reduce the risk of perfo-
rator occlusion.
The PED was originally approved for the 
treatment of aneurysms proximal to the 
PCOM artery.14 PCOMA aneurysms are 
among the most frequently encountered 
cerebral aneurysms. A fetal PCOM artery 
is an end vessel with no distal collaterals. 
Since fetal PCOM arteries represent the 
only supply to the PCA, care should be 
taken when treating PCOM aneurysms 
incorporating a fetal variant.19 In fact, fetal 
PCOM artery aneurysms are often treated 
surgically since endovascular therapy is 
thought to cause a higher treatment risk.19 
Several reports have suggested that flow 
diversion for fetal PCOM aneurysms is 
ineffective and does not lead to aneu-
rysm occlusion and has high potential 
for serious complications.17,19 Aneurysms 
arising from a fetal PCOM are less likely 
to be occluded even after placement of 
a flow diverter due to the high flow and 
the high physiological demand for this 
artery which maintains pressure gradient 
across the ostium.14 PCOM aneurysms 
with a fetal PCA are better to be treated 
with microsurgical clipping.18 Attempting 
flow diversion may add procedural risks 
and make surgical clipping even more 
technically complex.
MCA aneurysms represent the third most 
common cause of subarachnoid hemor-
rhage and almost 1/5 of unruptured 
aneurysms.24 The majority of MCA aneu-
rysms arise at the level of the bifurcation 
tend to be wide-necked, incorporate one 
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must recross the PED over the delivery 
wire to recapture the distal coil tip after 
complete stent deployment. Up to 50% 
foreshortening is expected when fully 
deployed compared with 1.5% -7.1% and 
1.8%-5.4% foreshortening in Wingspan® 
and Neuroform® 3 stents. (Bench testing 
conducted by Boston Scientific) 
There is a potential risk of an endoleak-
like phenomenon with implantation of an 
undersized device, which results in poor 
wall apposition. Similarly, implantation of 
an oversized device may result in poor 
coverage of the lesion because of an 
incomplete compaction of the strands.31 
When a branch vessel is incorporated 
into the target aneurysm, its runoff 
can potentially contribute to persistent 
filling of the aneurysm by the very same 
physiological processes theoretically 
responsible for the preservation of jailed 
branch vessels and perforators arising 
from normal segments. One may expect 
that final closure of such aneurysms 
would require concomitant occlusion of 
the associated branch.
While the PED can allow for treatment of 
large, wide-necked aneurysms with high 
efficacy, aneurysm location, previous 
treatment, patient age and the use of 
concomitant coiling may influence treat-
ment outcomes.
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competitive modalities for intracranial 
aneurysm treatment.3 Using coils along 
with the PED in select cases can be more 
effective with a higher occlusion rate and 
lower retreatment rate, by promoting 
endosaccular thrombosis and providing 
a mechanical scaffold. 
The PED is indicated for large and giant 
aneurysms.4 However, large and giant 
aneurysms represent a small fraction of 
all cerebral aneurysms with the majority 
of aneurysms in the general population 
being <10 mm in size. Traditional endo-
vascular strategies including coiling and 
stent-assisted coiling are usually used 
for small aneurysms (≤ 7 mm). Some 
retrospective studies have demonstrated 
high occlusion rates (75-90%) and low 
complication rates (<5%) with treating 
these small aneurysms.10 In experienced 
centers the PED is demonstrating a 
better efficacy profile and a similar safety 
profile to coiling of smaller aneurysms.10 
With the increasing use of the PED for the 
treatment of small, simple aneurysms, 
the question arises as to whether the use 
of this device routinely, or even as a first 
line treatment for these aneurysms is as 
safe and effective as the current standard 
endovascular techniques. This needs to 
be further studied
Good clinical outcomes have been 
reported with flow diversion of saccular 
or non-symptomatic fusiform posterior 
circulation aneurysms.3 Treatment with 
the PED may be a preferable alternative 
to open surgical treatment for these 
aneurysms. Because of the large number 
of perforating vessels in the posterior 
circulation that supply vital brainstem 
structures, complex aneurysm anatomy, 
and aneurysm location, flow diversion 
should be used with caution. Aneurysm 
morphology and presentation are critical 
factors to consider when selecting 
posterior circulation aneurysms for 
treatment with the PED.30
Device deployment is successful in 95% 
to 100% of cases (99% in PUFS).2 Selec-
tion of the appropriate diameter and 
length of the device is essential to ensure 
proper device function and to minimize 
the chance for unanticipated stent 
shortening or migration. (FDA-Summary 
of Safety and Effectiveness of Data, 
PED, P100018) The delivery catheter 
or more side branch vessels and tend to 
have an unfavorable anatomical configu-
ration.15 Wide-necked MCA bifurcation 
lesions have been classically treated 
with microsurgery with excellent results. 
Traditional endovascular approaches can 
sometimes be challenging with a risk of 
occluding branch vessels as well as the 
risk of coil herniation. Flow diversion for 
MCA aneurysms should be considered 
when other surgical or endovascular 
approaches are not an option or do not 
offer superior outcomes and for lesions 
that persist after previous surgery or 
endovascular treatment.26 Clinical data 
should demonstrate better or similar 
results than clipping to challenge surgical 
intervention, with current occlusion rates 
from clipping reported to be >90% in 
most studies.25
Stent placement negatively affects the 
safety and efficacy of the PED in the 
management of recurrent aneurysms. 
The rate of complete aneurysm occlusion 
is lower in previously stented aneurysms 
(50-65%) with potential for a higher 
complication rate (14.3%) and tech-
nical failure rate.28 If a stent was placed 
initially, recurrence would be less eligible 
for PED treatment and might require 
surgical clipping to achieve aneurysm 
occlusion. The presence of a previous 
stent may: reduce the hemodynamic 
effect of the PED, disrupt the process of 
wall apposition of the PED to the parent 
vessel, preventing the endothelialization 
process inhibiting complete aneurysm 
occlusion, complicate the navigation of 
the delivery catheter into position and 
the actual deployment of the PED and 
because the PED should be deployed 
distal to the stent, the distal end of the 
PED may “catch” on the previously placed 
stent, which may cause anchoring and 
stretching of the device, leading to less 
effective results. It is important to note 
that patients of advanced age can have a 
weaker neo-intimal response and there-
fore may have higher odds of incomplete 
aneurysm occlusion.
The majority of cases require the place-
ment of only one PED, and a single PED 
should be usually placed as there was no 
difference in aneurysm occlusion when 
more than 1 device were deployed.29 
Coiling and flow diversion have been 
shown to be complementary, rather than 
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